Status | Study |
Recruiting |
Study Name: Celecoxib for Primary Prophylaxis of Combat-Related Heterotopic Ossification Condition: Ossification, Heterotopic Date: 2012-06-27 Interventions: Drug: Celecoxib 200 mg Q 12 hours orally Other Name: |
Completed |
Study Name: Evaluation of Fusion Rate of Anterior Cervical Discectomy and Fusion (ACDF) Using Cervios ChronOs™ and Bonion™ Condition: Intervertebral Disk Degeneration Intervertebral Disk Displacement Date: 2012-06-06 Interventions: Device: Cervios ChronOs The AC |
Active, not recruiting |
Study Name: Influence of Naproxen on Heterotropic Bone Formation Following Hip Arthroscopy Condition: Heterotopic Ossification Date: 2012-01-12 Interventions: Drug: Naproxen • Group 1 |
Completed |
Study Name: Prevention of Heterotopic Ossification With Arcoxia After Total Hip Replacement Condition: Ossification, Heterotopic Date: 2009-11-27 Interventions: Drug: Etoricoxib (Arcoxia) Oral intake of 90 mg Etoricoxib (Arcoxia) during 7-days |
Completed |
Study Name: Radiation Therapy for Heterotopic Ossification Prophylaxis Acutely After Elbow Trauma Condition: Elbow Fracture Date: 2009-10-07 Interventions: Radiation: Radiation Therapy (XRT) The dose will be 700 cGy in a single fraction, using AP-PA fields cal |
Withdrawn |
Study Name: Naproxen for the Prevention of HO After Complex Elbow Trauma Condition: Heterotopic Ossification Date: 2007-12-14 Interventions: Drug: Naproxen 500 mg Naproxen twice a day for two weeks |
Withdrawn |
Study Name: Study of Pamidronate for the Prevention of Heterotopic Ossification Condition: Heterotopic Ossification Date: 2005-12-05 Interventions: Drug: Pamidronate (AREDIA) Pamidronate (AREDIA) vs radiation |
Completed |
Study Name: Prevention of Ectopic Bone Related Pain and Disability After Hip Replacement Surgery With Peri-Operative Ibuprofen Condition: Osteoarthritis, Hip Arthroplasty, Replacement, Hip Arthrit Date: 2005-09-02 Interventions: Drug: Ibuprofen |